Kamada Pharmaceuticals' IPO - II Round

Kamada Pharmaceuticals raised a round of funding on May 31, 2013. Investors include Public.

Kamada Pharmaceuticals develops, produces and markets a line of specialty life-saving therapeutics using its proprietary chromatographic purification technologies. Kamada is traded on the Tel Aviv Sto…

Articles about Kamada Pharmaceuticals' IPO - II Round: